primary care + addiction medicine doc @pennmedicine @CAMP_penn | researching substance use treatment + harm reduction | @NCSP_Penn @ucsfDGIM alum
Philadelphia, PA
Joined October 2014
- Tweets272
- Following882
- Followers812
- Likes972
Really excited to share our work out in Annals of EM
Paper: annemergmed.com/article/S019…
Press release: pennmedicine.org/news/news-r…
@kit_delgadoMD @JMPerroneMD @nicolemodonnell #rachelmcfadden #jeffmoon
Now that the X-waiver has been X’ed (acep.org/news/acep-newsroom-…) , we have a huge potential pool of buprenorphine prescribers in EDs.
We have more work to do, but we hope strategies like ours can help other EDs out there trying to do this work.
Thanks to the many people involved from ED leadership, clinicians, IT, and our funders @PennInjury.
@PennLDI @CAMP_Penn @PennNudgeUnit
Maggie Lowenstein retweeted
First big steps toward freedom for people on methadone! SAMHSA released "The Guidance" today authorizing increased take-home bottles and a decreased focus on drug-screens for people who are doing well. Push your local OTP to change!
Maggie Lowenstein retweeted
Our team and colleagues presenting at ASAM today on Buprenorphine Telehealth @JMPerroneMD @nicolemodonnell @m_lowenstein
So proud of @_earth2brittany for this great work!
Impt work led by our ED buprenorphine coordinator @_earth2brittany w mentorship from @m_lowenstein. Dispensing harm reduction education w fentanyl test strips targeting pts who use stimulants #ASAM2023 @UPennEM @PennMedicine @ASAMorg @CAMP_Penn @nicolemodonnell @especially_APT
Maggie Lowenstein retweeted
Cool study of academic 🏥 re role of consultants in mgt of recurrent IDU-endocarditis by @jess_meisner @m_lowenstein. When cardiac surg decides alone they typically decline operation (86%). Small sample but in line w/our 2020 survey of cardiac surgeons. 1/
sciencedirect.com/science/ar…
Check out this amazing work led by @especially_APT to improve care for patients with opioid use disorder in the hospital.
This Post is from an account that no longer exists. Learn more
Maggie Lowenstein retweeted
New research out in @nejmcatalyst finds that the telemedicine program CareConnect helps eliminate barriers to treatment for patients with opioid use disorder (#OUD) ft. @m_lowenstein, @JMPerroneMD & @nicolemodonnell (@CAMP_penn) bit.ly/3Os2N2K
Kudos to @Jas_B417 and the whole team for this amazing work
catalyst.nejm.org/doi/abs/10…
Thx @aubreyjwhelan @PhillyInquirer for coverage of our @PennMedicine safety net CareConnect warmline for substance use tx. Grateful for dedicated @CAMP_Penn team @nicolemodonnell @m_lowenstein Jasmine, Gilly @_earth2brittany inquirer.com/health/suboxone…
Maggie Lowenstein retweeted
Thx @aubreyjwhelan @PhillyInquirer for coverage of our @PennMedicine safety net CareConnect warmline for substance use tx. Grateful for dedicated @CAMP_Penn team @nicolemodonnell @m_lowenstein Jasmine, Gilly @_earth2brittany inquirer.com/health/suboxone…
Excited to share new work in @nejmcatalyst describing the implementation of CareConnect, a virtual buprenorphine bridge clinic staffed by substance use navigators in partnership with @PennMedicine OnDemand and @PHLPublicHealth 🧵
catalyst.nejm.org/doi/full/1…
And thanks to the whole team @CAMP_Penn @JMPerroneMD Kathryn Gallagher Jon Pomeroy @khchaiyachati Susan McGinley Emily Cubbage @_earth2brittany @shoshiaronowitz @rachel_e_french